News

Deutetrabenazine (used to treat tardive dyskinesia) and Dexmedetomidine (a sedative) were removed from the  Possible Risk of TdP category and are no longer on the QTdrugs list. Our analysis of new evidence did not support their continued placement on the list.  As demonstrated by these revisions, the QTdrugs list is dynamic and can change frequently.